huC242-DM4

· ImmunoGen, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for huC242-DM4, covering 2010-03-17 to 2015-08-26. Get the full timeline:

Most recent: Clinical Trial Update: huC242-DM4 Treating Patients With Metastatic Gastric or Gastroesophageal Junction Carcinomas [Phase 2]